Rationale and design of the rigorous atrial analysis in advanced interatrial block (ARABIA) prospective study

Manuel Martínez-Sellés1, Vanesa Bruña2, Juan Lacalzada-Almeida3

  • 1Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Universidad Europea. Universidad Complutense, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.

Insights

Advanced interatrial block (IAB) in older adults is linked to clinical events. This study investigates IAB, P-wave duration, and atrial imaging in relation to atrial fibrillation, stroke, cognitive decline, and mortality.

Area of Science:

  • Cardiology
  • Geriatrics
  • Medical Imaging

Background:

  • Advanced interatrial block (IAB) affects 10% of individuals aged 75 and older.
  • IAB is associated with an increased risk of clinical events in the elderly population.

Purpose of the Study:

  • To determine the association between advanced IAB, P-wave duration, atrial imaging parameters, and clinical events.
  • To assess the relationship between P-wave duration, atrial imaging, and cerebral microemboli.

Main Methods:

  • Prospective multicenter study including 356 subjects aged ≥75 years.
  • Inclusion of 178 patients with advanced IAB and 178 matched controls with normal P-wave.
  • Utilizing electrocardiogram, advanced transthoracic echocardiography, and cardiac/brain MRI with a 2-year follow-up.

Main Results:

  • The study aims to identify associations between advanced IAB, P-wave duration, and various atrial imaging parameters (e.g., strain, volume, fibrosis, asynchrony).
  • Clinical outcomes investigated include atrial fibrillation, stroke, cognitive impairment, and mortality.
  • Secondary analysis will explore links between P-wave duration, atrial imaging, and cerebral microemboli.

Conclusions:

  • This research will provide crucial data on the clinical significance of advanced IAB and related atrial abnormalities in older adults.
  • Findings will elucidate the role of P-wave duration and atrial imaging in predicting adverse clinical events and cerebral microemboli.
Abstract